INTRODUCTION
Hearing loss is one of the most common human health problems, affecting one in 700-1000 newborns [1] . Deafness can be caused by gene alternations and environmental factors including the ototoxic drugs such as aminoglycoside antibiotics. Of the hereditary factors, variants in mitochondrial DNA (mtDNA), especially in 12S rRNA and tRNA Ser(UCN) genes, are the important causes of sensorineural hearing loss [2] ; among these variants, the homo-plasmic A1555G and C1494T pathogenic variants in the highly conserved A-site of 12S rRNA has been associated with both aminoglycoside-induced and nonsyndromic hearing loss (AINHL) in many families worldwide [3] [4] [5] [6] . Moreover, the A7445G, 7472insC, T7510C and T7511C pathogenic variants have been identified in the tRNA Ser(UCN) gene [7] . However, matrilineal relatives within and among families carrying these mutations exhibited a wide range of penetrance, severity and age at onset in hearing loss [8] [9] , moreover, functional analysis of the cell lines derived from the matrilineal relatives carrying these primary mutations demonstrated that the A1555G or C1494T led to mild mitochondrial dysfunction and sensitivity to aminoglycosides [10] [11] . These findings strongly indicated that the A1555G or C1494T pathogenic variants were insufficient to produce enough clinical phenotypes, thus, other factors, such as aminoglycosides, nuclear genes or mitochondrial haplotypes may contribute to the clinical expression of deafness-associated mtDNA variants.
With the aim of elucidating the molecular basis of hearing loss, an extensive mutational screening for mitochondrial 12S rRNA and tRNA Ser(UCN) genes were performed in the Hangzhou area of Zhejiang Province, People's Republic of China (PRC). In this report, we describe a Han Chinese family with maternally-inherited AINHL. Sequence analysis of the mitochondrial genome showed the presence of C1494T and G7444A pathogenic variants.
MATERIALS AND METHODS
Subjects. As a part of genetic screening program for hearing loss, a three-generation Han Chinese family (as shown in Figure 1 ) was found at the Department of Otolaryngology, Hangzhou First People's Hospital, Zhejiang Province, PRC. Informed consent was obtained from the participants. Blood samples were obtained from all participants prior to their participation in the study, in accordance with the Ethics Committee of Hangzhou First People's Hospital. In addition, a comprehensive history and physical examination were performed to identify any syndromic findings, the history of the use of aminoglycosides, as well as the genetic factors related to the hearing impairment in members of this pedigree. An age-appropriate audiological examination was performed, and this examination included pure tone audiometry (PTA) and auditory brainstem response (ABR), immittance testing and distortion product otoacoustic emissions. The PTA was calculated from the sum of the audiometric thresholds at 500, 1000, 2000, 4000 and 8000 Hz. The severity of hearing impairment was classified into five grades: normal <26 dB, mild 26-40 dB, moderate 41-70 dB, severe 71-90 dB and profound >90 dB. Moreover, DNA was obtained from 200 control subjects from a panel of unaffected Han Chinese subjects from the same region who were clinically tested.
Analysis of the Mutations in the Mitochondrial Genome. Genomic DNA was isolated from whole blood of participants using the Puregene DNA Isolation Kits (Gentra Systems, Minneapolis, MN, USA). First, three matrilineal relatives (I-2, II-5, III-2) and control subject's DNA fragments spanning the mitochondrial 12S rRNA and tRNA Ser(UCN) genes were amplified by polymerase chain reaction (PCR) using oligodeoxynucleotides as previously described [12] . Subsequently, the entire mitochondrial genomes of the deaf patients (I-2, II-5, III-2) and controls were PCR-amplified in 24-overlapping fragments using the set of light-strand and the heavy-strand primers [12] . After PCR amplification, each fragment was purified and analyzed by direct sequencing in an ABI PRISM™ 3700 automated DNA sequencer using the BigDye Terminator Cycle sequencing reaction kit (Applied Biosystems Inc., Foster City, CA, USA). The sequence data were compared with the reversed Cambridge sequence to detect the mutations (GenBank accession no. NC_012920) [13] .
Phylogenetic Analysis. A total of 17 vertebrates' mitochondrial genome sequences were used in the interspecific analysis. These include Bos Taurus Mutational Screening for the GJB2 Gene. The DNA fragments spanning the entire coding region of the GJB2 gene were amplified by PCR using the following primers: forward (5'-TAT GA CAC TCC CCA GCA CAG-3') and reverse (5'-GGG CAA TGC TTA AAC TGG C-3'). Polymerase chain reaction amplification and sequencing analyses were performed as described elsewhere [14] . The results were compared with the wild-type GJB2 sequence to identify the variants (GenBank Accession No. M86849).
Mutational Analysis of the TRMU Gene. A previous study showed that the TRMU exon 1 A10S variant may modulate the phenotypic manifestation of deafnessassociated mitochondrial 12S rRNA mutations [15] . To see whether TRMU played an active role in deafness expression, we conducted a mutational screening for the TRMU exon 1 in matrilineal relatives in this pedigree and the healthy controls. The primers for detecting the A10S variant were as follows: forward (5'-ACA GCG CAG AAG AAG AGC 
RESULTS
Clinical Features of the Han Chinese Family with AINHL. All patients from the Han Chinese family lived in Hangzhou City of Zhejiang Province. The proband (III-2) was an infant born in Hangzhou First People's Hospital. As shown in Table 1 and Figure 2 , the proband exhibited bilateral hearing impairment (90 dB right ear and 95 dB left ear). A comprehensive history and physical examination were performed to identify any syndromic findings, and the history of use of aminoglycosides. Moreover, we noticed that the proband's mother (II-5), a young woman at the age of 26 years; had been administered gentamicin (5 mg/kg/dose, 10 days) for fever when she was 18-yearsold. She developed the profound hearing loss 2 months after the drug administration. It is interesting to note that two matrilineal relatives (I-2, II-5), who had a history of exposure to gentamicin and streptomycin, exhibited a severe hearing impairment in this maternal kindred, suggesting that the aminoglycosides may play an important role in this disorder.
Screening for the Mutations in the Mitochondrial Genome. The maternal transmission of hearing loss in this family suggested a mitochondrial involvement and led us to analyze the mitochondrial genome of matrilineal relatives (I-2, II-5, III-2) and the healthy subjects. We To elucidate the molecular basis for maternally transmitted deafness, 24-overlapping DNA fragments spanning the entire mitochondrial genome were PCR-amplified and sequenced. The comparison of the resultant sequence with the Cambridge consensus sequence identified a set of polymorphisms, as shown in Table 2 . Among these, there were five variants in the D-loop, two known variants in the 12S rRNA and two variants in the 16S rRNA genes, while other variants were mainly localized at protein-coding genes. Moreover, we noticed that there were four amino acid substitutions caused by corresponding mtDNA variants occurring in different polypeptides. These missense variants included the ND1 C3497T (A64V), A6 A8860G (T112A), ND3 A10398G (T114A) and Cytb A15326G (T194A). These variants in rRNAs and polypeptides were further evaluated by phylogenetic analysis from other organisms including mouse [16] , bovine [17] and Xenopus laevis [18] . However, none of the variants in the polypeptides were highly evolutionarily conserved and implicated to have functional consequences.
Mutational Analysis of the GJB2 and TRMU Genes. To examine the role of the GJB2 and TRMU genes in phe-notypic expression of the C1494T pathogenic variant, we performed the mutational screening of GJB2 and TRMU exon 1 in matrilineal relatives who carried the C1494T pathogenic variant. However, none of the variants were found in the GJB2 and TRMU genes, suggesting that the GJB2 and TRMU genes may not play an important role in this Chinese family.
DISCUSSION
In this study, we have performed clinical, genetic and molecular characterization of a three-generation Han Chinese family with AINHL. Hearing impairment as a sole clinical phenotype was mostly present in the maternal lineage of this pedigree, suggesting that the mtDNA variant was the molecular basis for this disorder. As shown in Figure 1 , this family exhibited a high penetrance of hearing loss, in particular, the penetrance of hearing loss in this family was 80.0 and 40.0%, when aminoglycoside was included and excluded. Table 2 . mtDNA sequence variants in this family with hearing impairment. Sequence analysis of the mitochondrial genome showed the presence of C1494T pathogenic variant in the 12S rRNA gene, in fact, this pathogenic variant was first identified in a large Chinese family with AINHL [6] . Functional characterizations of cell lines derived from the C1494T pathogenic variant led to only mild mitochondrial dysfunction and sensitivity to aminoglycosides [11] . In addition, three affected matrilineal relatives exhibited the various severities, age at onset of hearing loss, suggesting that the C1494T pathogenic variant itself was insufficient to produce the clinical phenotypes; other modifying factors such as environmental factors, aminoglycosides, mitochondrial haplotype and nuclear genes were involved in deafness expression.
Gene
In addition, the mitochondrial haplotype has been shown to influence the penetrance of hearing loss associated with mtDNA primary mutations. In particular, mtDNA variants at positions 4216 and 13708, acting as second Lebers' hereditary optic neuropathy (LHON) variants, were implicated to increase the penetrance of the deafnessassociated A7445G pathogenic variant [19] . Moreover, the T5628C variant in tRNA Ala was thought to have a modifying role in the phenotypic manifestation of the C1494T pathogenic variant in a Han Chinese family [20] . In this study, the sequence analysis of the entire mitochondrial genome identified a set of polymorphisms, apart from C1494T and G7444A pathogenic variants, other variants in the mitochondrial genome showed no evolutionary conservation. As shown in Figures 3 and 4 , the G7444A pathogenic variant resulted in a read-through of the stop condon AGA of the COI message, thereby adding three amino acids (Lys-Gln-Lys) to the C-terminal of the polypeptide. Thus, the mutated polypeptide may retain a partial function. Alternatively, the G7444A pathogenic variant was adjacent to the site of 3' end endonucleolytic processing of the L-strand RNA precursor, spanning tRNA Ser(UCN) and ND6 mRNA [19] . The previous study showed that the A7445G pathogenic variant in the precursor of tRNA Ser(UCN) led to a failure in the processing of the L-strand RNA precursor, thereby causing a marked decrease of the steady-state levels of tRNA Ser(UCN) and ND6 mRNA [19] . Thus, the G7444A pathogenic variant, similar to the A7445G pathogenic variant, may also cause a defect in the processing of the L-strand RNA precursor, thus causing mitochondrial dysfunction. Although aminoglycoside was the predominant factor for hearing impairment, the G7444A pathogenic variant may also play an important role in the phenotypic expression of the C1494T pathogenic variant in this Chinese family. Moreover, due to the lack of any functional variants in GJB2 and TRMU genes, those nuclear genes may not play active roles in deafness expression. Taken together, our data showed that the combination of the C1494T and G7444A pathogenic variants in the mitochondrial genome, as well as the aminoglycosides may account for the high penetrance and expression of hearing loss in this family.
In summary, our study indicated that the combination of the C1494T and G7444A pathogenic variants in the mitochondrial genome, combined with the aminoglycosides, may account for the high penetrance and expression of AINHL in this family. Moreover, the incomplete penetrance, variable degree of hearing loss in matrilineal relatives suggested that other modified factors, such as epigenetic modification and environmental factors may contribute to the clinical expression of hearing loss in this family.
